CVintra in replicate designs (→ 2 IBDs) [General Sta­tis­tics]

posted by Helmut Homepage – Vienna, Austria, 2021-01-05 10:38 (200 d 07:53 ago) – Posting: # 22176
Views: 752

Hi clinicalservices,

» We are planning to conduct Steady State study having study design as- T1, T2, R, R.
» What should be our approach for calculation of Intra subject variability for such study design.

What’s the purpose of the study – a pilot study to select either T1 or T2 for a pivotal study?

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,589 posts in 4,512 threads, 1,530 registered users;
online 7 (0 registered, 7 guests [including 4 identified bots]).
Forum time: Saturday 19:31 CEST (Europe/Vienna)

There are no dangerous thoughts;
thinking itself is dangerous.    Hannah Arendt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5